Research and Development

The Research and Development team at Spirovant Sciences is dedicated to advancing novel gene therapies for cystic fibrosis and other pulmonary diseases. By collaborating across various scientific disciplines, including upstream and downstream process development, analytical testing, and laboratory management, the team focuses on innovating and refining therapeutic solutions to improve patient outcomes and drive the progress of gene therapy initiatives.